Clinical Trials · NCT00006368
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novartis Pharmaceuticals
- Enrollment
- 60
- Start date
- Jan 1998
- Locations
- 1 site, United States
- Primary endpoint
- Study in Brain and Central Nervous System Tumors